EDGE Surgical Expands Reach with $250,000 Ortho Tech Solutions Agreement

January 28, 2026 9:00 AM

EDGE Surgical, Inc., the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced a $250,000 agreement with Orth Tech Solutions as an authorized distributor for the Ortho EDG® Universal Electronic Depth Gauge in northern Ohio and southern Michigan.This relationship comes at an important moment, propelled by the increasing demand for the Ortho EDG®. Ortho Tech Solutions will distribute the company's...

Read more

Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting

January 28, 2026 8:30 AM

Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it delivered an invited presentation at a TechWatch meeting with the Biomedical Advanced Research and Development Authority (BARDA) on January 26, 2026, with select members of the Department of Defense (DoD), Defense Threat Reduction Agency (DTRA), National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases...

Read more

Tenon(R) Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025

January 28, 2026 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today issued a letter to shareholders from Steve Foster, President and Chief Executive Officer.Dear Fellow Shareholders,2025 was marked by strong commercial execution as we advanced innovation and expanded our differentiated solutions in the marketplace. We delivered both sequential and year over year...

Read more

Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations

January 28, 2026 8:00 AM

Strados Labs, a medical technology company advancing respiratory care through wearable technologies, today announced an observational research study evaluating remote lung sound monitoring in patients with chronic obstructive pulmonary disease (COPD) using its FDA 510(k) cleared RESP® Biosensor.The study, titled SL-RS-SHORE (NCT06544928), will take place at Jefferson Einstein Philadelphia Hospital and affiliated outpatient pulmonary clinics....

Read more

Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain

January 28, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced it has enrolled 50% of subjects targeted for interim review in its pivotal Phase 3 clinical trial of PF614, the Company's next-generation opioid candidate engineered to deliver powerful pain relief with built-in abuse...

Read more

Dr. Sophia Maurasse Elevates Mental Healthcare in Massachusetts with Personalized, Evidence-Based Psychiatric Care

January 28, 2026 8:00 AM

Psychiatry Massachusetts, LLC, led by board-certified psychiatrist Dr. Sophia Maurasse, MD, today announces its mission to provide Massachusetts residents with patient-centered, individualized psychiatric care that addresses the whole person - not just symptoms - across the lifespan. Dr. Maurasse's approach integrates clinical expertise with genuine human connection, offering clarity, support, and long-term well-being for patients and families...

Read more

Mentavi Health Reflects on a Defining 2025 and Outlines Responsible Growth Plans for 2026

January 28, 2026 6:45 AM

Mentavi Health, a leader in evidence-based digital mental health care, today released its 2025 Year in Review, highlighting a year marked by peer-reviewed clinical validation, broad institutional adoption, and continued leadership in ethical, human-centered mental health care. The company also outlined its priorities for 2026, centered on trusted partnerships, responsible innovation, and expanded access to high-quality mental health services for...

Read more

Who Is the Best Plastic Surgeon In Washington State?

January 28, 2026 6:00 AM

In Washington's competitive plastic surgery market, patients increasingly rely on verifiable sources when comparing plastic surgeons, from training history and procedural specialization to independent reviews. One Seattle-based surgeon repeatedly appears in these statewide searches: Dr. Javad Sajan. Known for advanced body contouring and gender-affirming surgical care, Dr. Sajan has performed over 4,000 surgical procedures. His profile has also...

Read more

Cantargia to Participate at Leerink Partners Global Healthcare Conference

January 28, 2026 4:15 AM

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA)(STO:CANTA) today announced that members of Cantargias management will participate in one-on-one meetings at the Leerink Partners Global Healthcare Conference in Miami, Florida on Wednesday, March 11, 2026.For further information, please contactHilde Steineger, CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected] CantargiaCantargia AB (publ), reg. no. 556791-6019, is a...

Read more

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities

January 28, 2026 2:00 AM

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Genflow Biosciences...

Read more

Patient Safety Movement Foundation Announces Dr. Jill Biden as Keynote Speaker at the 12th Annual World Patient Safety, Science & Technology Summit

January 27, 2026 6:25 PM

The Patient Safety Movement Foundation (PSMF) today announced that Dr. Jill Biden, former First Lady of the United States and longtime advocate for patients, families, and healthcare workers, will serve as the Keynote Speaker at the upcoming 12th Annual World Patient Safety, Science & Technology Summit, to be held at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California on February 27, 2026. Global leaders in patient safety,...

Read more

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026

January 27, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its second quarter of fiscal 2026, after the market close on Tuesday, February 3, 2026. The Company has scheduled a conference call and webcast that same day, Tuesday, February...

Read more

TRNR Publishes Shareholder Letter and Investor Presentation with 2026 Revenue Guidance of More Than $20M

January 27, 2026 1:45 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, and FORME brands, today published a shareholder letter update and an updated investor presentation on its website.In today's shareholder letter, the TRNR CEO, Trent Ward, provided an update on the multiple ways that TRNR could benefit from the Sportstech situation, noting that the Company is progressing in...

Read more

Lena Esmail Debunks 5 Harmful Myths About Local Healthcare

January 27, 2026 11:10 AM

Healthcare doesn't have to be confusing-but common myths often make it feel that way. Lena Esmail, a board-certified nurse practitioner and CEO of QuickMed, is speaking out to correct five widespread misunderstandings about local care access, providers, and urgent care systems."People aren't avoiding care because they don't care about their health," Esmail says. "They just often don't know where to start-or worse, they've been told things that...

Read more

Psyence Group's RTO Target, GoldCoast Resource Corp., Granted Offshore Reconnaissance License for Gold Exploration on Ghana's Shallow Continental Shelf

January 27, 2026 9:50 AM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that its proposed reverse takeover target, GoldCoast Resource Corp. ("GoldCoast"), has been granted a series of ten contiguous offshore reconnaissance licenses by the Minerals Commission of Ghana (the "Reconnaissance Licenses") covering approximately 10,000 square kilometres along Ghana's western offshore continental shelf (the "License Area"). The Reconnaissance Licenses...

Read more

ASCP Expands Age-Friendly Pharmacy Program With New Recognition Guide and Online Application

January 27, 2026 9:30 AM

As part of the organization's Age-Friendly Initiative, the American Society of Consultant Pharmacists (ASCP) has designed in partnership with the University of Maryland School of Pharmacy's (UMSOP) Peter Lamy Center on Drug Therapy and Aging a new Age-Friendly Pharmacy (AFP) recognition. AFP recognition is designed to elevate pharmacists and pharmacy practice sites with acknowledgement and support."Peer and public recognition for pharmacies...

Read more

Cellev8 Receives Official Name Change by FINRA

January 27, 2026 9:20 AM

Preferred Commerce announced today that it has received final approval from the Financial Industry Regulatory Authority (FINRA) to change its corporate name to Cellev8 Nutrition Inc. (CELV), marking a major milestone in the company's path toward becoming a category-defining brand in cellular wellness and next-generation nutrition."This is very important to our path forward," said Michael Ferraro, CEO and Founder of Cellev8 Nutrition Inc....

Read more

Revecore Reports Record Growth in 2025 as Health Systems Intensify Focus on Revenue Cycle Performance

January 27, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced a record-breaking 2025 marked by a 26% increase in new business, expanded engagements with existing customers, key additions to the executive leadership team, industry recognition, and new partnership initiatives. This momentum underscores the company's rapid growth and position as a comprehensive, outcomes-driven partner...

Read more

CLn Skin Care’s ProStrength Wash Named 2025 Top Pick in Skin Anarchy Beauty Awards

January 27, 2026 9:00 AM

CLn Skin Care, a leader in dermatologist-recommended skincare, is proud to announce that CLn ProStrength Wash has been named a 2025 Top Pick in the Skin Anarchy Beauty Awards, earning recognition in the Body Care: Wash & Scrub category.The annual Skin Anarchy Beauty Awards celebrate standout products across the beauty and personal care industry, highlighting formulations that combine innovation, performance, and thoughtful ingredient selection....

Read more

CNS Pharmaceuticals Issues Letter to Shareholders

January 27, 2026 9:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today issued a Letter to Shareholders from its newly appointed President and Chief Executive Officer, Rami Levin.Dear Fellow Shareholders,I am honored to write to you for the first time in my role as President and Chief...

Read more